膽堿受體阻斷藥課件_第1頁
膽堿受體阻斷藥課件_第2頁
膽堿受體阻斷藥課件_第3頁
膽堿受體阻斷藥課件_第4頁
膽堿受體阻斷藥課件_第5頁
已閱讀5頁,還剩73頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

膽堿受體阻斷藥CholinoceptorBlockingDrugs成都大學(xué)醫(yī)護(hù)學(xué)院藥理教研室王躍锜原創(chuàng)膽堿受體阻斷藥CholinoceptorBlocking1

MuscarinicCholinoceptorBlockingDrugs

毒蕈堿型受體阻斷藥,M受體阻斷藥2NicotinicCholinoceptorBlockingDrugs

煙堿型受體阻斷藥,N受體阻斷藥IntroductiontoCholinoceptorBlockingDrugs

膽堿受體阻斷藥1MuscarinicCholinoceptorBloMuscarinicCholinoceptorBlockingDrugs毒蕈堿型受體阻斷藥,M受體阻斷藥ReceptorTypeOtherNamesLocation部位M1

Nerves神經(jīng)M2

CardiacM2

Heart,nerves,smoothmuscle心臟,神經(jīng),平滑肌M3

Glands,smoothmuscle,endothelium腺體,平滑肌,內(nèi)皮細(xì)胞M4

CNS中樞神經(jīng)系統(tǒng)M5

CNSNM

Muscletype,endplatereceptor肌肉型,終板受體Skeletalmuscleneuromuscularjunction骨骼肌神經(jīng)肌肉接頭NN

Neuronaltype,ganglionreceptor神經(jīng)元型,神經(jīng)節(jié)受體postganglioniccellbody,dendrites突觸后細(xì)胞,樹突MuscarinicCholinoceptorBlockAtropine阿托品tertiaryaminealkaloidestersoftropicacid莨菪酸的叔胺生物堿酯Propantheline丙胺太林,普魯本辛Quaternaryamineantimuscarinicagents季胺類化合物Atropine阿托品tertiaryaminealkMosttertiaryantimuscarinicdrugs(叔胺類抗膽堿藥)

arewellabsorbedfromthegut(消化道)

andconjunctivalmembranes(結(jié)膜).Incontrast,only10–30%ofadoseofaquaternaryantimuscarinicdrug(季胺類抗膽堿藥)

isabsorbedafteroraladministration(口服),reflectingthedecreasedlipidsolubilityofthechargedmolecule(帶電荷的分子).Absorption吸收

MosttertiaryantimuscarinicdDistribution分布

Atropineandtheothertertiaryagents(叔胺類抗膽堿藥)arewidelydistributedinthebody.SignificantlevelsareachievedintheCNS(中樞神經(jīng)系統(tǒng))within30minutesto1hour,andthiscanlimitthedosetoleratedwhenthedrugistakenforitsperipheraleffects.Scopolamine(東莨菪堿)israpidlyandfullydistributedintotheCNSwhereithasgreatereffectsthanmostotherantimuscarinicdrugs.Incontrast,thequaternaryderivatives(季胺類抗膽堿藥)arepoorlytakenupbythebrainandthereforearerelativelyfree—atlowdoses—ofCNSeffects.Distribution分布AtropineandAfteradministration,theelimination消除ofatropinefromthebloodoccursinapproximately15hours.About50%ofthedoseisexcretedunchangedintheurine尿.Mostoftherestappearsintheurineashydrolysis水解andconjugationproducts結(jié)合物.Thedrug‘seffectonparasympathetic副交感functiondeclinesrapidlyinallorgansexcepttheeye.Effectsontheiris瞳孔andciliarymuscle睫狀肌persistformorethan72hours.MetabolismandExcretion代謝與消除Afteradministration,theelimAtropinecausesreversible(surmountable可逆的)blockadeatmuscarinicreceptors;thatis,blockadebyasmalldoseofatropinecanbeovercomebyalargerconcentrationofacetylcholine乙酰膽堿

orequivalentmuscarinicagonistM受體阻斷藥.Tissues組織mostsensitivetoatropinearethesalivary唾液腺,bronchial支氣管,andsweatglands汗腺.Secretionofacidbythegastricparietalcells胃壁細(xì)胞

istheleastsensitive.Pharmacodynamics藥效作用Atropinecausesreversible(suAtropineishighlyselective選擇性formuscarinicreceptorsM型受體.Itspotency效力atnicotinicreceptorsN型受體ismuchlower.Atropinedoesnotdistinguish區(qū)分

amongtheM1,M2,andM3subgroups亞型

ofmuscarinicreceptors.Incontrast,otherantimuscarinicdrugsaremoderatelyselectiveforoneoranotherofthesesubgroups.Atropineishighlyselective選CentralNervousSystem中樞神經(jīng)系統(tǒng)

Inthedosesusuallyused,atropine阿托品

hasminimalstimulanteffects興奮效應(yīng)

ontheCNS,andaslower,longer-lastingsedative鎮(zhèn)靜effectonthebrain.Scopolamine東莨菪堿hasmoremarkedcentraleffects,producingdrowsiness嗜睡whengiveninrecommendeddosagesandamnesia失憶insensitiveindividuals.Intoxicdoses中毒劑量,scopolamine,andtoalesserdegreeatropine,cancauseexcitement興奮,agitation

焦躁,hallucinations幻覺,andcoma昏迷.Pharmacodynamics:藥效

器官效應(yīng)OrganSystemEffectsCentralNervousSystem中樞神經(jīng)系統(tǒng)PEye眼前房角變窄睫狀肌松弛擴(kuò)瞳畏光,調(diào)節(jié)麻痹房水回流受阻淚腺分泌減少,眼干澀Eye眼前房角變窄淚腺分泌減少,眼干澀CardiovascularSystem心血管系統(tǒng)心率上升,房室傳導(dǎo)加快CardiovascularSystem心率上升,房室傳導(dǎo)RespiratorySystem呼吸系統(tǒng)支氣管分泌減少,支氣管擴(kuò)張RespiratorySystem呼吸系統(tǒng)支氣管分泌減GastrointestinalTract消化道Blockadeofmuscarinicreceptorshasdramaticeffectsonmotility運(yùn)動

andsomeofthesecretory分泌functionsofthegut腸道.AntimuscarinicdrugsM型抗膽堿藥

havemarkedeffectsonsalivarysecretion唾液分泌;

drymouthoccursfrequentlyinpatientstakingantimuscarinicdrugs.Gastricsecretion胃酸分泌isblockedlesseffectively.Gastrointestinalsmoothmusclemotility胃腸平滑肌運(yùn)動isaffectedfromthestomach胃tothecolon結(jié)腸.Ingeneral,thewallsoftheviscera內(nèi)臟

arerelaxed,andbothtone張力

andpropulsivemovements蠕動arediminished.Therefore,gastricemptyingtime胃排空時間

isprolonged,andintestinaltransittimeislengthened.GastrointestinalTract消化道GenitourinaryTract泌尿道Theantimuscarinicactionofatropineanditsanalogs同類藥

relaxessmoothmuscleoftheureters輸尿管

andbladderwall膀胱壁andslowsvoiding排尿.

SweatGlands汗腺體溫上升,皮膚血流增加散熱降低皮膚變干汗液減少GenitourinaryTractSweatGlanOphthalmologicDisorders

眼科Accuratemeasurementofrefractiveerror屈光不正

inuncooperativepatients,eg,youngchildren,requiresciliaryparalysis睫狀肌麻痹.Also,ophthalmoscopicexamination眼底鏡檢查oftheretina視網(wǎng)膜isgreatlyfacilitatedbymydriasis散瞳.Therefore,antimuscarinicagents,administeredtopicallyaseyedrops眼藥水orointment眼膏,areveryhelpfulindoingacompleteexamination.Foradultsandolderchildren,theshorter-actingdrugsarepreferred(如后馬托品,托吡卡胺).Foryoungerchildren,thegreaterefficacyofatropineissometimesnecessary.Asecondophthalmologicuseistopreventsynechia(adhesion粘連)formationinuveitis葡萄膜炎andiritis虹膜炎.Clinicalapplications臨床應(yīng)用OphthalmologicDisorders眼科ClAntimuscarinicDrugsUsedinOphthalmology眼科使用的M型抗膽堿藥DrugDurationofEffect(days)作用持續(xù)時間UsualConcentration(%)常用濃度Atropine阿托品7–100.5–1Scopolamine東莨菪堿3–70.25Homatropine后馬托品1–32–5Tropicamide托吡卡胺0.250.5–1AntimuscarinicDrugsUsedinORespiratoryDisorders呼吸系統(tǒng)Theuseofatropine阿托品becamepartofroutinepreoperativemedication術(shù)前給藥whenanesthetics麻醉suchasether乙醚wereused,becausetheseirritant刺激性anestheticsmarkedlyincreasedairwaysecretions分泌andwereassociatedwithfrequentepisodesoflaryngospasm喉痙攣.Preanesthetic麻醉前injectionofatropine阿托品

orscopolamine東莨菪堿

couldpreventthesehazardouseffects.RespiratoryDisorders呼吸系統(tǒng)CardiovascularDisorders

心血管系統(tǒng)Markedreflexvagaldischarge迷走神經(jīng)反射性興奮

sometimesaccompaniesthepainofmyocardialinfarction心肌梗塞(eg,vasovagalattack血管迷走神經(jīng)性發(fā)作)andmayimpaircardiacoutput心輸出.Parenteral注射atropineorasimilarantimuscarinicdrugisappropriatetherapyinthissituation.Rareindividualswithoutotherdetectablecardiacdiseasehavehyperactivecarotidsinusreflexes頸動脈竇反射andmayexperiencefaintness眩暈

orevensyncope昏厥asaresultofvagaldischarge迷走興奮

inresponsetopressureontheneck,eg,fromatightcollar.Suchindividualsmaybenefitfromtheuseofatropineorarelatedantimuscarinicagent.CardiovascularDisorders心血管系GastrointestinalDisorders

消化道Antimuscarinicagentscanprovidesomereliefinthetreatmentofmildorself-limitedconditionsofhypermotility胃腸平滑肌過度興奮.UrinaryDisorders

泌尿系統(tǒng)Atropineandotherantimuscarinicdrugshavebeenusedtoprovidesymptomaticreliefinthetreatmentofurinaryurgency尿急causedbyminorinflammatorybladderdisorders膀胱炎.GastrointestinalDisorders消化CholinergicPoisoning

膽堿能中毒Severecholinergicexcessisamedicalemergency,especiallyinruralcommunitieswherecholinesteraseinhibitorinsecticides殺蟲劑arecommonlyusedandincultureswherewildmushrooms毒蘑菇arecommonlyeaten.Thepotentialuseofcholinesteraseinhibitorsaschemicalwarfare“nervegases“神經(jīng)毒氣

alsorequiresanawarenessofthemethodsfortreatingacutepoisoning.CholinergicPoisoning膽堿能中毒Overdoses過量ofatropineoritscongeners同類藥aregenerallytreatedsymptomatically對癥治療.Poisoncontrolexpertsdiscouragetheuseofphysostigmine毒扁豆堿oranothercholinesteraseinhibitor膽堿酯酶抑制藥toreversetheeffectsofatropineoverdosebecausesymptomaticmanagementismoreeffectiveandlessdangerous.Symptomatictreatmentmayrequiretemperaturecontrolwithcoolingblanketsandseizure癲癇controlwithdiazepam安定.Artificialrespiratorysupportisneededinrespiratorydepression.AntimuscarinicPoisoning抗膽堿藥中毒Overdoses過量ofatropineoritsContraindicationstotheuseofantimuscarinicdrugsarerelative相對禁忌,notabsolute.Obviousmuscarinicexcess,especiallythatcausedbycholinesteraseinhibitors膽堿酯酶抑制藥,canalwaysbetreatedwithatropine.Antimuscarinicdrugsarecontraindicatedinpatientswithglaucoma青光眼,especiallyangle-closureglaucoma急性閉角型青光眼.Inelderlymen,antimuscarinicdrugsshouldalwaysbeusedwithcautionandshouldbeavoidedinthosewithahistoryofprostatichyperplasia

前列腺肥大.Contraindications禁忌癥Contraindicationstotheuseo1Ganglionicblockingdrugs

神經(jīng)節(jié)阻斷藥2Skeletalmuscularrelaxants

骨骼肌松弛劑Nicotiniccholinoceptor

blockingdrugs煙堿型受體阻斷藥N受體阻斷藥1GanglionicblockingdrugsNicGanglionicblockingdrugs

神經(jīng)節(jié)阻斷藥GanglionPreganglionicfiberPostganglionicfiberGanglionicblockingdrugs

神經(jīng)節(jié)阻Mecamylamine美加明andtrimethaphan咪噻吩isoccasionallyusedinthetreatmentofhypertensiveemergencies高血壓危象anddissectingaorticaneurysm主動脈夾層動脈瘤;inproducinghypotension低血壓,whichcanbeofvalueinneurosurgery神經(jīng)手術(shù)toreducebleedingintheoperativefield.Clinicalapplications臨床應(yīng)用Mecamylamine美加明andtrimethaphaNeuromuscularblockingdrugsinterferewithtransmissionattheneuromuscularendplate終板.Thesecompoundsareusedprimarilyasadjuncts輔助用藥duringgeneralanesthesia全身麻醉tofacilitatetrachealintubation氣管插管andoptimizesurgicalconditionswhileensuringadequateventilation通氣.Skeletalmuscularrelaxants

骨骼肌松弛劑NeuromuscularblockingdrugsiMechanismofneuromuscularblocked作用機(jī)制Mechanismofneuromuscularblo1Nondepolarizingmuscularrelaxants(d-tubocurarine筒箭毒堿)

非除極化肌松藥2Depolarizingmuscularrelaxants(succinylcholine琥珀酰膽堿)

除極化肌松藥1Nondepolarizingmuscularrel筒箭毒堿Nondepolarizingmuscularrelaxants非除極化肌松藥筒箭毒堿Nondepolarizingmuscularr膽堿受體阻斷藥課件Duringanesthesia麻醉,administrationoftubocurarine筒箭毒堿initiallycausesmotorweakness,followedbytheskeletalmusclesbecomingflaccid松弛的andinexcitabletoelectricalstimulation.Ingeneral,largermuscles(eg,abdominal腹肌,trunk軀干,diaphragm)橫隔膜aremoreresistanttoneuromuscularblockadeandrecovermorerapidlythansmallermuscles(eg,facial面部,foot,hand).Thediaphragm膈肌

isusuallythelastmuscletobeparalyzed麻痹.Whenadministrationofmusclerelaxantsisdiscontinued,recoveryofmusclesusuallyoccursinreverseorder,withthediaphragmregainingfunctionfirst.Clinicalapplications臨床應(yīng)用Duringanesthesia麻醉,administr乙酰膽堿Depolarizingmuscularrelaxants

除極化肌松藥琥珀酰膽堿乙酰膽堿Depolarizingmuscularrela膽堿受體阻斷藥課件Followingtheadministrationofsuccinylcholine琥珀酰膽堿,transientmusclefasciculations肌束震顫

occuroverthechest胸部andabdomen腹部within30seconds.Asparalysis麻痹developsrapidly(<90seconds),thearm,neck,andlegmusclesareinitiallyrelaxedfollowedbytherespiratorymuscles呼吸肌.Asaresultofsuccinylcholine‘srapidhydrolysis水解bycholinesteraseintheplasma血漿(andliver),thedurationofneuromuscularblocktypicallylastslessthan10minutes.Clinicalapplications臨床應(yīng)用FollowingtheadministrationoTubocurarine筒箭毒堿Succinylcholine琥珀酰膽堿PhaseIPhaseIIEffectofneostigmine新斯的明的影響AntagonisticAugmented1

AntagonisticInitialexcitatoryeffectonskeletalmuscle骨骼肌初始的表現(xiàn)NoneFasciculations肌束震顫NoneTubocurarineSuccinylcholine琥A63-year-oldarchitect,complainsofurinarysymptomstohisfamilyphysician.Hehashypertensionandthelast8years,hehasbeenadequatelymanagedwithathiazidediuretic噻嗪類利尿藥andanangiotensin-convertingenzymeinhibitor.Duringthesameperiod,hedevelopedthesignsofbenignprostatichypertrophy,whicheventuallyrequiredprostatectomy前列腺切除torelievesymptoms.Henowcomplainsthathehasanincreasedurgetourinateaswellasurinaryfrequency,andthishasdisruptedthepatternofhisdailylife.Whattreatmentstepswouldyouinitiate?CaseStudyA63-year-oldarchitect,complA53-year-oldwomancomestoseeyouforaconsultation.SheisscheduledtotakeaCaribbeancruisein2weeksbutisconcernedaboutseasickness.Shehasbeenonboatsbeforeandisverysensitivetomotionsickness.Afriendmentionedtoherthatthereisapatchthatiseffectiveforthisproblem.Sheisingoodhealthandtakesnomedicationsregularly.Herexaminationisnormal.Youprescribeascopolaminetransdermalpatchforher.

·Whatisthemechanismofactionofscopolamine?

·Whatarethecommonsideeffectsofthismedication?

·Whataresomerelativecontraindicationstoitsuse?CaseStudyA53-year-oldwomancomestosMechanismofactionofscopolamine:Competitiveantagonistofmuscariniccholinoreceptorsinthevestibularsystemandthecentralnervoussystem(CNS).

Commonsideeffects:Mydriasis,drymouth,tachycardia,urinaryretention,confusion,drowsiness.

Relativecontraindications:Glaucoma,urinaryobstruction,heartdisease.

ANSWERSTOCASEMechanismofactionofscopola膽堿受體阻斷藥CholinoceptorBlockingDrugs成都大學(xué)醫(yī)護(hù)學(xué)院藥理教研室王躍锜原創(chuàng)膽堿受體阻斷藥CholinoceptorBlocking1

MuscarinicCholinoceptorBlockingDrugs

毒蕈堿型受體阻斷藥,M受體阻斷藥2NicotinicCholinoceptorBlockingDrugs

煙堿型受體阻斷藥,N受體阻斷藥IntroductiontoCholinoceptorBlockingDrugs

膽堿受體阻斷藥1MuscarinicCholinoceptorBloMuscarinicCholinoceptorBlockingDrugs毒蕈堿型受體阻斷藥,M受體阻斷藥ReceptorTypeOtherNamesLocation部位M1

Nerves神經(jīng)M2

CardiacM2

Heart,nerves,smoothmuscle心臟,神經(jīng),平滑肌M3

Glands,smoothmuscle,endothelium腺體,平滑肌,內(nèi)皮細(xì)胞M4

CNS中樞神經(jīng)系統(tǒng)M5

CNSNM

Muscletype,endplatereceptor肌肉型,終板受體Skeletalmuscleneuromuscularjunction骨骼肌神經(jīng)肌肉接頭NN

Neuronaltype,ganglionreceptor神經(jīng)元型,神經(jīng)節(jié)受體postganglioniccellbody,dendrites突觸后細(xì)胞,樹突MuscarinicCholinoceptorBlockAtropine阿托品tertiaryaminealkaloidestersoftropicacid莨菪酸的叔胺生物堿酯Propantheline丙胺太林,普魯本辛Quaternaryamineantimuscarinicagents季胺類化合物Atropine阿托品tertiaryaminealkMosttertiaryantimuscarinicdrugs(叔胺類抗膽堿藥)

arewellabsorbedfromthegut(消化道)

andconjunctivalmembranes(結(jié)膜).Incontrast,only10–30%ofadoseofaquaternaryantimuscarinicdrug(季胺類抗膽堿藥)

isabsorbedafteroraladministration(口服),reflectingthedecreasedlipidsolubilityofthechargedmolecule(帶電荷的分子).Absorption吸收

MosttertiaryantimuscarinicdDistribution分布

Atropineandtheothertertiaryagents(叔胺類抗膽堿藥)arewidelydistributedinthebody.SignificantlevelsareachievedintheCNS(中樞神經(jīng)系統(tǒng))within30minutesto1hour,andthiscanlimitthedosetoleratedwhenthedrugistakenforitsperipheraleffects.Scopolamine(東莨菪堿)israpidlyandfullydistributedintotheCNSwhereithasgreatereffectsthanmostotherantimuscarinicdrugs.Incontrast,thequaternaryderivatives(季胺類抗膽堿藥)arepoorlytakenupbythebrainandthereforearerelativelyfree—atlowdoses—ofCNSeffects.Distribution分布AtropineandAfteradministration,theelimination消除ofatropinefromthebloodoccursinapproximately15hours.About50%ofthedoseisexcretedunchangedintheurine尿.Mostoftherestappearsintheurineashydrolysis水解andconjugationproducts結(jié)合物.Thedrug‘seffectonparasympathetic副交感functiondeclinesrapidlyinallorgansexcepttheeye.Effectsontheiris瞳孔andciliarymuscle睫狀肌persistformorethan72hours.MetabolismandExcretion代謝與消除Afteradministration,theelimAtropinecausesreversible(surmountable可逆的)blockadeatmuscarinicreceptors;thatis,blockadebyasmalldoseofatropinecanbeovercomebyalargerconcentrationofacetylcholine乙酰膽堿

orequivalentmuscarinicagonistM受體阻斷藥.Tissues組織mostsensitivetoatropinearethesalivary唾液腺,bronchial支氣管,andsweatglands汗腺.Secretionofacidbythegastricparietalcells胃壁細(xì)胞

istheleastsensitive.Pharmacodynamics藥效作用Atropinecausesreversible(suAtropineishighlyselective選擇性formuscarinicreceptorsM型受體.Itspotency效力atnicotinicreceptorsN型受體ismuchlower.Atropinedoesnotdistinguish區(qū)分

amongtheM1,M2,andM3subgroups亞型

ofmuscarinicreceptors.Incontrast,otherantimuscarinicdrugsaremoderatelyselectiveforoneoranotherofthesesubgroups.Atropineishighlyselective選CentralNervousSystem中樞神經(jīng)系統(tǒng)

Inthedosesusuallyused,atropine阿托品

hasminimalstimulanteffects興奮效應(yīng)

ontheCNS,andaslower,longer-lastingsedative鎮(zhèn)靜effectonthebrain.Scopolamine東莨菪堿hasmoremarkedcentraleffects,producingdrowsiness嗜睡whengiveninrecommendeddosagesandamnesia失憶insensitiveindividuals.Intoxicdoses中毒劑量,scopolamine,andtoalesserdegreeatropine,cancauseexcitement興奮,agitation

焦躁,hallucinations幻覺,andcoma昏迷.Pharmacodynamics:藥效

器官效應(yīng)OrganSystemEffectsCentralNervousSystem中樞神經(jīng)系統(tǒng)PEye眼前房角變窄睫狀肌松弛擴(kuò)瞳畏光,調(diào)節(jié)麻痹房水回流受阻淚腺分泌減少,眼干澀Eye眼前房角變窄淚腺分泌減少,眼干澀CardiovascularSystem心血管系統(tǒng)心率上升,房室傳導(dǎo)加快CardiovascularSystem心率上升,房室傳導(dǎo)RespiratorySystem呼吸系統(tǒng)支氣管分泌減少,支氣管擴(kuò)張RespiratorySystem呼吸系統(tǒng)支氣管分泌減GastrointestinalTract消化道Blockadeofmuscarinicreceptorshasdramaticeffectsonmotility運(yùn)動

andsomeofthesecretory分泌functionsofthegut腸道.AntimuscarinicdrugsM型抗膽堿藥

havemarkedeffectsonsalivarysecretion唾液分泌;

drymouthoccursfrequentlyinpatientstakingantimuscarinicdrugs.Gastricsecretion胃酸分泌isblockedlesseffectively.Gastrointestinalsmoothmusclemotility胃腸平滑肌運(yùn)動isaffectedfromthestomach胃tothecolon結(jié)腸.Ingeneral,thewallsoftheviscera內(nèi)臟

arerelaxed,andbothtone張力

andpropulsivemovements蠕動arediminished.Therefore,gastricemptyingtime胃排空時間

isprolonged,andintestinaltransittimeislengthened.GastrointestinalTract消化道GenitourinaryTract泌尿道Theantimuscarinicactionofatropineanditsanalogs同類藥

relaxessmoothmuscleoftheureters輸尿管

andbladderwall膀胱壁andslowsvoiding排尿.

SweatGlands汗腺體溫上升,皮膚血流增加散熱降低皮膚變干汗液減少GenitourinaryTractSweatGlanOphthalmologicDisorders

眼科Accuratemeasurementofrefractiveerror屈光不正

inuncooperativepatients,eg,youngchildren,requiresciliaryparalysis睫狀肌麻痹.Also,ophthalmoscopicexamination眼底鏡檢查oftheretina視網(wǎng)膜isgreatlyfacilitatedbymydriasis散瞳.Therefore,antimuscarinicagents,administeredtopicallyaseyedrops眼藥水orointment眼膏,areveryhelpfulindoingacompleteexamination.Foradultsandolderchildren,theshorter-actingdrugsarepreferred(如后馬托品,托吡卡胺).Foryoungerchildren,thegreaterefficacyofatropineissometimesnecessary.Asecondophthalmologicuseistopreventsynechia(adhesion粘連)formationinuveitis葡萄膜炎andiritis虹膜炎.Clinicalapplications臨床應(yīng)用OphthalmologicDisorders眼科ClAntimuscarinicDrugsUsedinOphthalmology眼科使用的M型抗膽堿藥DrugDurationofEffect(days)作用持續(xù)時間UsualConcentration(%)常用濃度Atropine阿托品7–100.5–1Scopolamine東莨菪堿3–70.25Homatropine后馬托品1–32–5Tropicamide托吡卡胺0.250.5–1AntimuscarinicDrugsUsedinORespiratoryDisorders呼吸系統(tǒng)Theuseofatropine阿托品becamepartofroutinepreoperativemedication術(shù)前給藥whenanesthetics麻醉suchasether乙醚wereused,becausetheseirritant刺激性anestheticsmarkedlyincreasedairwaysecretions分泌andwereassociatedwithfrequentepisodesoflaryngospasm喉痙攣.Preanesthetic麻醉前injectionofatropine阿托品

orscopolamine東莨菪堿

couldpreventthesehazardouseffects.RespiratoryDisorders呼吸系統(tǒng)CardiovascularDisorders

心血管系統(tǒng)Markedreflexvagaldischarge迷走神經(jīng)反射性興奮

sometimesaccompaniesthepainofmyocardialinfarction心肌梗塞(eg,vasovagalattack血管迷走神經(jīng)性發(fā)作)andmayimpaircardiacoutput心輸出.Parenteral注射atropineorasimilarantimuscarinicdrugisappropriatetherapyinthissituation.Rareindividualswithoutotherdetectablecardiacdiseasehavehyperactivecarotidsinusreflexes頸動脈竇反射andmayexperiencefaintness眩暈

orevensyncope昏厥asaresultofvagaldischarge迷走興奮

inresponsetopressureontheneck,eg,fromatightcollar.Suchindividualsmaybenefitfromtheuseofatropineorarelatedantimuscarinicagent.CardiovascularDisorders心血管系GastrointestinalDisorders

消化道Antimuscarinicagentscanprovidesomereliefinthetreatmentofmildorself-limitedconditionsofhypermotility胃腸平滑肌過度興奮.UrinaryDisorders

泌尿系統(tǒng)Atropineandotherantimuscarinicdrugshavebeenusedtoprovidesymptomaticreliefinthetreatmentofurinaryurgency尿急causedbyminorinflammatorybladderdisorders膀胱炎.GastrointestinalDisorders消化CholinergicPoisoning

膽堿能中毒Severecholinergicexcessisamedicalemergency,especiallyinruralcommunitieswherecholinesteraseinhibitorinsecticides殺蟲劑arecommonlyusedandincultureswherewildmushrooms毒蘑菇arecommonlyeaten.Thepotentialuseofcholinesteraseinhibitorsaschemicalwarfare“nervegases“神經(jīng)毒氣

alsorequiresanawarenessofthemethodsfortreatingacutepoisoning.CholinergicPoisoning膽堿能中毒Overdoses過量ofatropineoritscongeners同類藥aregenerallytreatedsymptomatically對癥治療.Poisoncontrolexpertsdiscouragetheuseofphysostigmine毒扁豆堿oranothercholinesteraseinhibitor膽堿酯酶抑制藥toreversetheeffectsofatropineoverdosebecausesymptomaticmanagementismoreeffectiveandlessdangerous.Symptomatictreatmentmayrequiretemperaturecontrolwithcoolingblanketsandseizure癲癇controlwithdiazepam安定.Artificialrespiratorysupportisneededinrespiratorydepression.AntimuscarinicPoisoning抗膽堿藥中毒Overdoses過量ofatropineoritsContraindicationstotheuseofantimuscarinicdrugsarerelative相對禁忌,notabsolute.Obviousmuscarinicexcess,especiallythatcausedbycholinesteraseinhibitors膽堿酯酶抑制藥,canalwaysbetreatedwithatropine.Antimuscarinicdrugsarecontraindicatedinpatientswithglaucoma青光眼,especiallyangle-closureglaucoma急性閉角型青光眼.Inelderlymen,antimuscarinicdrugsshouldalwaysbeusedwithcautionandshouldbeavoidedinthosewithahistoryofprostatichyperplasia

前列腺肥大.Contraindications禁忌癥Contraindicationstotheuseo1Ganglionicblockingdrugs

神經(jīng)節(jié)阻斷藥2Skeletalmuscularrelaxants

骨骼肌松弛劑Nicotiniccholinoceptor

blockingdrugs煙堿型受體阻斷藥N受體阻斷藥1GanglionicblockingdrugsNicGanglionicblockingdrugs

神經(jīng)節(jié)阻斷藥GanglionPreganglionicfiberPostganglionicfiberGanglionicblockingdrugs

神經(jīng)節(jié)阻Mecamylamine美加明andtrimethaphan咪噻吩isoccasionallyusedinthetreatmentofhypertensiveemergencies高血壓危象anddissectingaorticaneurysm主動脈夾層動脈瘤;inproducinghypotension低血壓,whichcanbeofvalueinneurosurgery神經(jīng)手術(shù)toreducebleedingintheoperativefield.Clinicalapplications臨床應(yīng)用Mecamylamine美加明andtrimethaphaNeuromuscularblockingdrugsinterferewithtransmissionattheneuromuscularendplate終板.Thesecompoundsareusedprimarilyasadjuncts輔助用藥duringgeneralanesthesia全身麻醉tofacilitatetrachealintubation氣管插管andoptimizesurgicalconditionswhileensuringadequateventilation通氣.Skeletalmuscularrelaxants

骨骼肌松弛劑NeuromuscularblockingdrugsiMechanismofneuromuscularblocked作用機(jī)制Mechanismofneuromuscularblo1Nondepolarizingmuscularrelaxants(d-tubocurarine筒箭毒堿)

非除極化肌松藥2Depolarizingmuscularrelaxants(succinylcholine琥珀酰膽堿)

除極化肌松藥1Nondepolarizingmuscularrel筒箭毒堿Nondepolarizingmuscularrelaxants非除極化肌松藥筒箭毒堿Nondepolarizingmuscularr膽堿受體阻斷藥課件Duringanesthesia麻醉,administrationoftubocurarine筒箭毒堿initiallycausesmotorweakness,followedbytheskeletalmusclesbecomingflaccid松弛的andinexcitabletoelectricalstimulation.Ingeneral,largermuscles(eg,abdominal腹肌,trunk軀干,diaphragm)橫隔膜aremoreresistanttoneuromuscularblockadeandrecovermorerapidlythansmallermuscles(eg,facial面部,foot,hand).Thediaphragm膈肌

isusuallythelastmuscletobeparalyzed麻痹.

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論